{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:37Z","timestamp":1790937157727,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001744","name":"The International Science & Technology Center","doi-asserted-by":"crossref","award":["#1638p"],"award-info":[{"award-number":["#1638p"]}],"id":[{"id":"10.13039\/501100001744","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Russian Federal Science & Technology Program","award":["43.035.1.1.1527"],"award-info":[{"award-number":["43.035.1.1.1527"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.virusres.2011.09.008","type":"journal-article","created":{"date-parts":[[2011,9,25]],"date-time":"2011-09-25T21:55:35Z","timestamp":1316987735000},"page":"141-150","source":"Crossref","is-referenced-by-count":14,"title":["The neutralizing human recombinant antibodies to pathogenic Orthopoxviruses derived from a phage display immune library"],"prefix":"10.1016","volume":"163","author":[{"given":"Nina","family":"Tikunova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Dubrovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Morozova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Khlusevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Bormotov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Laman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor","family":"Brovko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Shvalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeni","family":"Belanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2011.09.008_bib0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1743-422X-6-188","article-title":"Inhibition of Monkeypox virus replication by RNA interference","volume":"6","author":"Alkhalil","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2011.09.008_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2011.09.008_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","article-title":"Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay","volume":"100","author":"Beatty","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virusres.2011.09.008_bib0020","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0025","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2011.09.008_bib0030","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of chimpanzee\/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0035","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0040","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/JVI.70.4.2627-2631.1996","article-title":"Identification and characterization of Vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans","volume":"70","author":"Demkowicz","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S0026893307010207","article-title":"Construction of combinatorial immune library of human single chain antibodies to Orthopoxviruses and selection of antibodies to recombinant prA30L of the variola virus","volume":"41","author":"Dubrovskaia","year":"2007","journal-title":"Mol Biol (Mosk)."},{"key":"10.1016\/j.virusres.2011.09.008_bib0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2011.09.008_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2007.02.041","article-title":"Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate","volume":"366","author":"Earl","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2011.09.008_bib0060","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.virusres.2011.09.008_bib0065","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1128\/JVI.00291-08","article-title":"Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo","volume":"82","author":"Goncalvez","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0070","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","article-title":"Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1","volume":"46","author":"Gorny","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0075","doi-asserted-by":"crossref","first-page":"14606","DOI":"10.1128\/JVI.79.23.14606-14613.2005","article-title":"Protective and therapeutic capacity of human single-chain Fv\u2013Fc fusion proteins against West Nile virus","volume":"79","author":"Gould","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0080","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(05)70234-8","article-title":"Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial","volume":"365","author":"Greenberg","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2011.09.008_bib0085","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/j.1460-2075.1994.tb06626.x","article-title":"Isolation of high affinity human antibodies directly from large synthetic repertoires","volume":"13","author":"Griffiths","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.virusres.2011.09.008_bib0090","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/422999","article-title":"Clinical efficacy of intramuscular vaccinia immune globulin: a literature review","volume":"39","author":"Hopkins","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2011.09.008_bib0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jviromet.2009.06.018","article-title":"Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library","volume":"161","author":"Houimel","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2011.09.008_bib0105","doi-asserted-by":"crossref","first-page":"e8912","DOI":"10.1371\/journal.pone.0008912","article-title":"Comparison of West African and Congo Basin monkeypox viruses in BALB\/c and C57BL\/6 mice","volume":"5","author":"Hutson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2011.09.008_bib0110","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/CVI.00037-06","article-title":"Human neutralizing Fab molecules against severe acute respiratory syndrome coronavirus generated by phage display","volume":"13","author":"Kang","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1542\/peds.18.2.177","article-title":"Hyperimmune vaccinial gamma globulin: source, evaluation and use in prophylaxis and therapy","volume":"18","author":"Kempe","year":"1956","journal-title":"Pediatrics"},{"key":"10.1016\/j.virusres.2011.09.008_bib0120","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1016\/j.vaccine.2010.05.060","article-title":"Chimeric antibodies against tick-borne encephalitis virus","volume":"28","author":"Levanov","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2011.09.008_bib0125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1743-422X-5-80","article-title":"Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library","volume":"5","author":"Lim","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2011.09.008_bib0130","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0135","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.vaccine.2009.01.038","article-title":"Effective post-exposure protection against lethal Orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response","volume":"27","author":"Lustig","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2011.09.008_bib0140","series-title":"Orthopoxviruses Pathogenic for Humans","author":"Marennikova","year":"1998"},{"key":"10.1016\/j.virusres.2011.09.008_bib0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0022-2836(91)90498-U","article-title":"By-passing immunization. Human antibodies from V-gene libraries displayed on phage","volume":"222","author":"Marks","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0150","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/eji.1830210419","article-title":"Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes","volume":"21","author":"Marks","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3851\/IMP1573","article-title":"Combination therapy of Vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model","volume":"15","author":"McCausland","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2011.09.008_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virusres.2004.07.011","article-title":"Variola and camelpox virus-specific sequences are part of a single large open reading frame identified in two German cowpox virus strains","volume":"108","author":"Meyer","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.virusres.2011.09.008_bib0165","series-title":"Fields Virology","first-page":"2905","article-title":"Poxviruses","author":"Moss","year":"2007"},{"key":"10.1016\/j.virusres.2011.09.008_bib0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-60327-302-2_9","article-title":"Isolation of scFvs that inhibit the NS3 protease of hepatitis C virus by a combination of phage display and a bacterial genetic screen","volume":"562","author":"Nahary","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0175","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/j.1460-2075.1994.tb06308.x","article-title":"Antibody fragments from a \u2018single pot\u2019 phage display library as immunochemical reagents","volume":"13","author":"Nissim","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.virusres.2011.09.008_bib0180","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.micinf.2009.07.010","article-title":"Recombinant human monoclonal antibodies to human cytomegalovirus glycoprotein B neutralize virus in a complement-dependent manner","volume":"11","author":"Ohta","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.virusres.2011.09.008_bib0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2217\/17460794.3.6.595","article-title":"Therapeutic and prophylactic drugs to treat orthopoxvirus infections","volume":"3","author":"Parker","year":"2008","journal-title":"Future Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0190","first-page":"3525","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccinations","volume":"74","author":"P\u00fctz","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2011.09.008_bib0195","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00705-006-0923-8","article-title":"Neutralization of animal virus infectivity by antibody","volume":"152","author":"Reading","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the western hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2011.09.008_bib0205","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/651560","article-title":"Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax","volume":"201","author":"Seaman","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2011.09.008_bib0210","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1086\/425039","article-title":"Human monkeypox infection: a family cluster in the midwestern United States","volume":"190","author":"Sejvar","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2011.09.008_bib0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/viro.1999.9701","article-title":"Production and characterization of human monoclonal antibody Fab fragments to vaccinia virus from a phage-display combinatorial library","volume":"258","author":"Schmaljohn","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2011.09.008_bib0220","first-page":"20","article-title":"Human recombinant antibodies to variola virus","volume":"50","author":"Tikunova","year":"2005","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0225","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE","volume":"28","author":"Von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2011.09.008_bib0230","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.4049\/jimmunol.171.9.4680","article-title":"Infant and adult human B cell responses to rotavirus. Share common immunodominant variable gene repertoires","volume":"171","author":"Weitkamp","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0235","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1128\/JVI.00106-07","article-title":"A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo","volume":"81","author":"Williams","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2011.09.008_bib0240","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3390\/v2102381","article-title":"Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections","volume":"2","author":"Xiao","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2011.09.008_bib0245","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170211003327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170211003327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:46:28Z","timestamp":1686357988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170211003327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0168170211003327"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2011.09.008","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}